Gritstone Oncology Inc (GRTS)

Gritstone Oncology Financial Statements

Gritstone Oncology Financial Overview

Gritstone Oncology's market cap is currently ―. The company's EPS TTM is $-1.45; its P/E ratio is -1.84; Gritstone Oncology is scheduled to report earnings on August 15, 2022, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement
Total Revenue$ 4.75M$ 1.78M$ 2.40M$ 2.84M$ 39.69M
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -28.96M$ -29.78M$ -28.16M$ -25.17M$ 7.90M
EBITDA$ -27.37M$ -28.22M$ -26.57M$ -23.57M$ 9.49M
Net Income Common Stockholders$ -28.92M$ -29.77M$ -28.12M$ -25.12M$ 7.92M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 70.55M$ 171.06M$ 171.18M$ 172.16M$ 198.01M
Total Assets$ 243.47M$ 278.11M$ 271.28M$ 224.22M$ 246.94M
Total Debt$ 21.25M$ 23.49M$ 24.76M$ 25.11M$ 26.11M
Net Debt$ -49.30M$ -147.56M$ -146.42M$ -147.06M$ -171.90M
Total Liabilities$ 54.28M$ 62.02M$ 63.33M$ 45.40M$ 47.59M
Stockholders Equity$ 71.98M$ 166.74M$ 178.82M$ 189.19M$ 199.35M
Cash Flow
Free Cash Flow$ -35.26M$ -25.11M$ -16.34M$ -24.35M$ 9.66M
Operating Cash Flow$ -33.45M$ -23.78M$ -14.87M$ -22.68M$ 10.65M
Investing Cash Flow$ 7.63M$ -46.63M$ 41.16M$ -23.49M$ -89.60M
Financing Cash Flow$ -917.00K$ 32.88M$ 56.74M$ 1.75M$ 17.39M
Currency in USD

Gritstone Oncology Earnings and Revenue History

Gritstone Oncology Debt to Assets

Gritstone Oncology Cash Flow

Gritstone Oncology Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis